The BBCIC is collaboration of managed care organizations, integrated delivery systems, pharmacy benefit management firms, research institutions and pharmaceutical companies. The BBCIC is the only research network dedicated to post-marketing assessment of biosimilars. To date the following organizations have made financial and in-kind commitments: AbbVie, Aetna/CVS Health Clinical Trial Services, Amgen, HealthCore Inc./Elevance Health, Apobiologix, Arthritis Foundation, Boehringer Ingelheim Pharmaceuticals, Inc, Express Scripts, Inc., Group Health Cooperative/Kaiser Permanente of Washington Research Institute, Harvard Pilgrim Health Care, HealthPartners, Henry Ford Health System, IQVIA, Momenta Pharmaceuticals, Inc., Merck, Optum, Patient Advocate Foundation, Pfizer, Sandoz and the Hematology Oncology Pharmacy Association.